BHC News and Press, Bausch Health Companies Inc. From 11/14/25

2025-11-14 17:18:12 ET More on Markets Novo Nordisk Stock: Buy And Forget Why I Have Been (And Remain) Negative On Consumer Stocks Ring Energy: The Game Continues Jana Partners exits Wex, takes new stake in Six Flags Entertainment among other Q3 moves ...

2025-11-14 16:36:55 ET Carl Icahn took a new stake in satellite communications provider EchoStar ( SATS ) in Q3 2025, while exiting his stake in Canadian pharmaceutical firm Bausch Health ( BHC ), among other moves. ... Read the full article on Seeking Alp...

2025-11-11 07:07:31 ET Investment thesis Read the full article on Seeking Alpha For further details see: Bausch Health: Solid Q3 Performance Reinforces Deleveraging Path

Expansion improves access to treatment options within periodontal care and helps strengthen partnerships with dental professionals within these populations. LAVAL, QC / ACCESS Newswire / November 5, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global diversified pharmaceutic...

2025-10-31 07:45:00 ET When Bausch Health Companies ( BHC ) posted third-quarter results, shares jumped to as high as almost $7.00 on the day. It ended up by 12.03% on October 30, up by 12.03%.... Read the full article on Seeking Alpha For further details see: Why Ba...

2025-10-29 20:27:27 ET More on Bausch Health Companies Bausch Health Companies Inc. (BHC) Q3 2025 Earnings Call Transcript Bausch Health: Repricing Continues As Deleveraging Gains Traction Why Bausch Health Stock Surged By Nearly 20% Bausch Health rises on 20...

2025-10-29 20:26:29 ET Bausch Health Companies Inc. (BHC) Q3 2025 Earnings Call October 29, 2025 5:00 PM EDT... Read the full article on Seeking Alpha For further details see: Bausch Health Companies Inc. (BHC) Q3 2025 Earnings Call Transcript

2025-10-29 17:53:11 ET More on Bausch Health Companies Bausch Health: Repricing Continues As Deleveraging Gains Traction Why Bausch Health Stock Surged By Nearly 20% Bausch Health Companies Q3 2025 Earnings Preview Bausch, Teva face lawsuit for delay in gener...

2025-10-29 16:37:19 ET More on Bausch Health Companies Bausch Health: Repricing Continues As Deleveraging Gains Traction Why Bausch Health Stock Surged By Nearly 20% Bausch Health Companies Q3 2025 Earnings Preview Bausch, Teva face lawsuit for delay in gener...

Third Quarter Consolidated Revenues of $2.68 billion, up 7% on a Reported basis and 5% on an Organic (non-GAAP) 1 basis over the prior year period GAAP Net Income Attributable to Bausch Health of $179 million and GAAP Net Income of $181 million Consolidated Adjusted EBITDA Attribut...